Skip to Main

Erik Surtevall is a core member of the Health Care and Principal Investors & Private Equity practices at Boston Consulting Group. Erik serves as the regional leader for BCG’s work in medical technologies (MedTech) in Europe, the Middle East, South America, and Africa.

Erik works with a broad range of clients in the health care industry, including companies in medical equipment and devices, in vitro diagnostics, and life science tools. His work is focused on growth strategy, innovation, operational improvement programs, and M&A. Erik also advises private equity clients on buy-side, sell-side, and portfolio company optimizations.

Since joining BCG in 2011, Erik has worked globally within his areas of expertise, including a year based in Boston.

AREAS OF EXPERTISE

EDUCATION

  • MSc, with distinction, finance, London School of Economics
  • BSc, business administration and economics, Lund University

Publications and Videos

" "

Medtech’s Path to a Circular Future

Most environmental waste generated by the health care sector comes from medtech products. For a sector focused on improving quality of life, reducing waste and greenhouse gases is imperative.
MedTech Green Moment Is Here | rectangle

MedTech’s Green Moment Is Here

Medical technology companies play a big part in health care’s carbon emissions problem, both at the patient and provider levels. Fortunately, these firms can reduce their footprint affordably.
" "

As Vaccines Roll Out, Testing Still Matters

Multiple scenarios for the US and four EU countries point to a continued need for COVID-19 testing through 2024, with demand peaking in the seasonally affected first quarters of 2021 and 2022.